These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8402230)

  • 61. Interleukin-21 and the IL-21 receptor: novel effectors of NK and T cell responses.
    Parrish-Novak J; Foster DC; Holly RD; Clegg CH
    J Leukoc Biol; 2002 Nov; 72(5):856-63. PubMed ID: 12429707
    [TBL] [Abstract][Full Text] [Related]  

  • 62. IL-5 receptor-mediated tyrosine phosphorylation of SH2/SH3-containing proteins and activation of Bruton's tyrosine and Janus 2 kinases.
    Sato S; Katagiri T; Takaki S; Kikuchi Y; Hitoshi Y; Yonehara S; Tsukada S; Kitamura D; Watanabe T; Witte O; Takatsu K
    J Exp Med; 1994 Dec; 180(6):2101-11. PubMed ID: 7525847
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Interleukin-10 inhibits both production of cytokines and expression of cytokine receptors in microglia.
    Sawada M; Suzumura A; Hosoya H; Marunouchi T; Nagatsu T
    J Neurochem; 1999 Apr; 72(4):1466-71. PubMed ID: 10098850
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Decreased expression of membrane IL-5 receptor alpha on human eosinophils: I. Loss of membrane IL-5 receptor alpha on airway eosinophils and increased soluble IL-5 receptor alpha in the airway after allergen challenge.
    Liu LY; Sedgwick JB; Bates ME; Vrtis RF; Gern JE; Kita H; Jarjour NN; Busse WW; Kelly EA
    J Immunol; 2002 Dec; 169(11):6452-8. PubMed ID: 12444154
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Selective inhibition of IL-5 receptor alpha-chain gene transcription by IL-5, IL-3, and granulocyte-macrophage colony-stimulating factor in human blood eosinophils.
    Wang P; Wu P; Cheewatrakoolpong B; Myers JG; Egan RW; Billah MM
    J Immunol; 1998 May; 160(9):4427-32. PubMed ID: 9574547
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Differential signalling for enhanced hexose uptake by interleukin (IL)-3 and IL-5 in male germ cells.
    Rauch MC; Brito M; Zambrano A; Espinoza M; Pérez M; Yañez A; Rivas CI; Slebe JC; Vera JC; Concha II
    Biochem J; 2004 Jul; 381(Pt 2):495-501. PubMed ID: 15018615
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Biology of recently discovered cytokines: interleukin-17--a unique inflammatory cytokine with roles in bone biology and arthritis.
    Gaffen SL
    Arthritis Res Ther; 2004; 6(6):240-7. PubMed ID: 15535837
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Interleukin-5 as a differentiation factor for eosinophilic granulocytes. Its biological effects and potential therapeutic uses].
    Kubin R
    Dtsch Med Wochenschr; 1992 Feb; 117(8):307-12. PubMed ID: 1537269
    [No Abstract]   [Full Text] [Related]  

  • 69. Interleukin 5 in the link between the innate and acquired immune response.
    Takatsu K; Kouro T; Nagai Y
    Adv Immunol; 2009; 101():191-236. PubMed ID: 19231596
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cytokine-specific transcriptional regulation through an IL-5Ralpha interacting protein.
    Geijsen N; Uings IJ; Pals C; Armstrong J; McKinnon M; Raaijmakers JA; Lammers JW; Koenderman L; Coffer PJ
    Science; 2001 Aug; 293(5532):1136-8. PubMed ID: 11498591
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Critical proline residues of the cytoplasmic domain of the IL-5 receptor alpha chain and its function in IL-5-mediated activation of JAK kinase and STAT5.
    Kouro T; Kikuchi Y; Kanazawa H; Hirokawa K; Harada N; Shiiba M; Wakao H; Takaki S; Takatsu K
    Int Immunol; 1996 Feb; 8(2):237-45. PubMed ID: 8671609
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Interleukin-5 and human B lymphocytes.
    Baumann MA; Paul CC
    Methods; 1997 Jan; 11(1):88-97. PubMed ID: 8990094
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Eosinophil differentiation factor (interleukin-5).
    Sanderson CJ
    Immunol Ser; 1990; 49():231-56. PubMed ID: 2090253
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Interleukin 5 regulation of peritoneal B-cell proliferation and antibody secretion.
    Wetzel GD
    Scand J Immunol; 1990 Jan; 31(1):91-101. PubMed ID: 2300791
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Down-regulated IL-5 receptor expression on peripheral blood eosinophils from budesonide-treated children with asthma.
    Hellman C; Lönnkvist K; Hedlin G; Halldén G; Lundahl J
    Allergy; 2002 Apr; 57(4):323-8. PubMed ID: 11906363
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Eosinophilic interleukin 5 (IL-5) transgenic mice: eosinophil activity and impaired clearance of Schistosoma mansoni.
    Dent LA; Munro GH; Piper KP; Sanderson CJ; Finlay DA; Dempster RK; Bignold LP; Harkin DG; Hagan P
    Parasite Immunol; 1997 Jul; 19(7):291-300. PubMed ID: 9278941
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Characterization of the human IL-5 receptors on eosinophils.
    Migita M; Yamaguchi N; Mita S; Higuchi S; Hitoshi Y; Yoshida Y; Tomonaga M; Matsuda I; Tominaga A; Takatsu K
    Cell Immunol; 1991 Apr; 133(2):484-97. PubMed ID: 2015632
    [TBL] [Abstract][Full Text] [Related]  

  • 78. IL-5 and eosinophilia.
    Takatsu K; Nakajima H
    Curr Opin Immunol; 2008 Jun; 20(3):288-94. PubMed ID: 18511250
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Characterization of ST2 transgenic mice with resistance to IL-33.
    Ohto-Ozaki H; Kuroiwa K; Mato N; Matsuyama Y; Hayakawa M; Tamemoto H; Tominaga S
    Eur J Immunol; 2010 Sep; 40(9):2632-42. PubMed ID: 20662097
    [TBL] [Abstract][Full Text] [Related]  

  • 80. In vivo administration of antibody to murine IL-5 receptor inhibits eosinophilia of IL-5 transgenic mice.
    Hitoshi Y; Yamaguchi N; Korenaga M; Mita S; Tominaga A; Takatsu K
    Int Immunol; 1991 Feb; 3(2):135-9. PubMed ID: 2025613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.